ORPHA:46486
Mucous membrane pemphigoid
Also known as: Cicatricial pemphigoid · Mucosal pemphigoid · Mucosynechial pemphigoid
Publications
4,521
95.7th percentile
Trials
12
Interventional, condition-specific
Researchers
1,020
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare autoimmune bullous skin disease characterized clinically by blistering of the mucous membranes followed by scarring, and immunologically characterized by IgG, IgA and/or C3 deposits on the epidermal basement membrane. The disease principally involves the oral mucosa, but may also affect ocular, pharyngolaryngeal, genital, and esophageal mucous membranes.
How rare: 1-9 / 1 000 000 — roughly one to nine people per million. In a city the size of Kolkata, perhaps a few dozen.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0018746
- UMLS:C0030804
- NCIT:C34907
Additional Mondo synonyms (3)
benign mucous Membrane pemphigoid · cicatricial pemphigoid · mucosal pemphigoid
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
4,521 matched papers (2,283 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
12 matched on ClinicalTrials.gov (1 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
4,521
4,521 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
4,521 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
2,283 in the last 10 years · high confidence · 95.7th percentile (publications denominator)
Phrase hits: 4,521 · MeSH hits: 0
Who's working on it?
1,020
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Basu S10 papers · 2026
Department of Ophthalmology and Visual Science, Cornea Service, Eye and Ear Infirmary, University of IL, University of Illinois at Chicago, Chicago, IL, USA.
Papers in Europe PMC - 02Schmidt E9 papers · 2026
Department of Dermatology, University of Lübeck, Lübeck, Germany.
Papers in Europe PMC - 03Li J7 papers · 2026
Department of Stomatology, The First Affiliated Hospital of Hunan Traditional Chinese Medical College (Hunan Provincial Directly Affiliated Hospital of Traditional Chinese Medicine), Zhuzhou, China.
Papers in Europe PMC - 04Ishii N6 papers · 2026
Department of Dermatology, Kurume University School of Medicine, Kurume, Japan.
Papers in Europe PMC - 05Kate A6 papers · 2026
From the UPMC Vision Institute, University of Pittsburgh School of Medicine (A.K., V.J.), Pittsburgh, Pennsylvania, USA.
Papers in Europe PMC - 06Hashimoto T5 papers · 2026
Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Papers in Europe PMC - 07Joly P5 papers · 2026
AIBD-ToxiTEN group of the ERN-skin, Univ Paris Est Créteil, EpiDermE, Créteil, France.
Papers in Europe PMC - 08Li X5 papers · 2026
Department of Laboratory Medicine, Chronic Disease Research Center, Medical College, Dalian University, Dalian 116622, China.
Papers in Europe PMC - 09Shanbhag SS5 papers · 2026
Shantilal Shanghvi Cornea Institute, L V Prasad Eye Institute, Hyderabad, Telangana, India.
Papers in Europe PMC - 10Wang Y5 papers · 2026
Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
12
interventional trials for this specific condition
12 interventional trials matched this specific condition name; 1 currently recruiting in our sample.
Data as of 27 July 2026
12 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 92.5th percentile).
high confidence · 92.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
12 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06926478·NOT YET RECRUITING·Subconjunctival Humira for Boston Keratoprosthesis
Conditions: Penetrating Keratoplasty · Multiple Graft Failure · Ocular Cicatricial Pemphigoid · Stevens-Johnson Syndrome·Matched via name phrase
Observational and natural-history studies
4 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT05954416·RECRUITING·FARD (RaDiCo Cohort) (RaDiCo-FARD)
Conditions: Inherited Epidermolysis Bullosa · Ichthyosis · Ectodermal Dysplasia · Incontinentia Pigmenti·Matched via name phrase
- NCT04198740·RECRUITING·Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Conditions: Dry Eye Syndrome · Infectious Keratoconjunctivitis · Mucous Membrane Pemphigoid · Allergic Conjunctivitis·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Mucous membrane pemphigoid" OR "Cicatricial pemphigoid" OR "Mucosal pemphigoid" OR "Mucosynechial pemphigoid" OR "benign mucous Membrane pemphigoid"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Mucous membrane pemphigoid" OR "Cicatricial pemphigoid" OR "Mucosal pemphigoid" OR "Mucosynechial pemphigoid" OR "benign mucous Membrane pemphigoid"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 12 interventional · 4 observational · 1 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T00:10:10.727Z
